Video Experimental Relacionado
Updated: Aug 21, 2026
04:41
Knee Arthrocentesis in Adults
Published on: February 25, 2022
Ibuprofeno en el tratamiento de la artritis gota aguda
JAMA
|January 2, 1978
Resumen
El ibuprofeno trató eficazmente la artritis aguda gotica en diez pacientes, con una resolución completa de los síntomas en 72 horas. Este fármaco antiinflamatorio no esteroide ofrece una opción de tratamiento segura y rápida para los brotes de gota.
Área de la Ciencia:
- Reumatología Reumatología.
- Farmacología Farmacología.
Sus antecedentes:
- El ibuprofeno es un fármaco antiinflamatorio no esteroide (AINE).
- Los AINE se usan comúnmente para la artritis reumatoide y la osteoartritis.
- La artritis aguda por gota es una condición inflamatoria dolorosa.
Objetivo del estudio:
- Para evaluar la eficacia del ibuprofeno en el tratamiento de la artritis aguda por gota.
- Evaluar la seguridad y las reacciones adversas del ibuprofeno en pacientes con gota.
Principales métodos:
- Se incluyeron diez pacientes con artritis gotica aguda.
- Se administraron dosis diarias de 2.400 mg de ibuprofeno.
- Se monitorearon los resultados de los pacientes y los eventos adversos.
Principales resultados:
- Los diez pacientes experimentaron una rápida mejora.
- La resolución completa de los síntomas de la artritis gota aguda se produjo dentro de las 72 horas.
- No se reportaron reacciones adversas durante el tratamiento con ibuprofeno.
Conclusiones:
- La terapia con ibuprofeno es un tratamiento eficaz para la artritis gota aguda.
- Las dosis altas de ibuprofeno demuestran un perfil de seguridad favorable en este grupo de pacientes.
- El ibuprofeno presenta una alternativa viable para el manejo de los brotes agudos de gota.
Videos de Conceptos Relacionados
01:23Treatment for Pulmonary Arterial Hypertension: Prostacyclin Receptor Agonists
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
01:29Drugs for Treatment of Ulcerative Colitis in IBD
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide generation.
01:29Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel Disease...
01:24Drugs for Treatment of Crohn's Disease in IBD Using Biologic Agents: Anti-TNF
Tumor Necrosis Factor (TNF), a proinflammatory cytokine, contributes significantly to the inflammation seen in Crohn's disease. It exists as soluble TNF and membrane-bound TNF, with actions mediated through TNF receptors (TNFR). TNFR activation leads to the release of proinflammatory cytokines, T-cell activation, collagen production, and leukocyte migration, all contributing to inflammation in Crohn's disease. Anti-TNF monoclonal antibodies, namely infliximab (Remicade), adalimumab (Humira),...
01:21Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2 (COX-2),...
01:29Inflammatory Bowel Disease IV: Pharmacological Management
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
Pharmacologic...